Transient Asymptomatic Sinus Bradycardia and Sinus Pauses with Bevacizumab: Case Report and Literature Review

Systemic side effects of anti-cancer therapy remain a major limiting factor for patients, even with targeted therapy. Bevacizumab is an example of targeted cancer therapy which targets the vascular endothelial growth factor receptor (VEGFR) that has been approved for the treatment of various cancers...

Descripción completa

Detalles Bibliográficos
Autores principales: Essa, Amr, Diab, Osama, Munir, Ahmed, Andukuri, Venkata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913932/
https://www.ncbi.nlm.nih.gov/pubmed/31890384
http://dx.doi.org/10.7759/cureus.6177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913932/
https://www.ncbi.nlm.nih.gov/pubmed/31890384
http://dx.doi.org/10.7759/cureus.6177

Ejemplares similares